Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (931-940 of 992) with videos related to

Pageof 100
Sort By:
Trials|July 21, 2023
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trialsSarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Microbiome|July 22, 2025
Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection modelPhilip M Ashton, Leonardos Mageiros, James E Meiring, et al.
Lancet (London, England)|January 25, 2022
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised studySue Ann Costa Clemens, Lily Weckx, Ralf Clemens, et al.
The Journal of Infectious Diseases|July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in CommunitiesDima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Nature Communications|January 14, 2025
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatmentSandra Viz-Lasheras, Alberto Gómez-Carballa, Xabier Bello, et al.
Archives of Disease in Childhood|August 28, 2023
External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised childrenAlexander James Martin, Fabian Johannes Stanislaus van der Velden, Ulrich von Both, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Pageof 100

Showing results (931-940 of 992) with videos related to

Sort By:
Pageof 100
Trials|July 21, 2023
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trialsSarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Microbiome|July 22, 2025
Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection modelPhilip M Ashton, Leonardos Mageiros, James E Meiring, et al.
Lancet (London, England)|January 25, 2022
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised studySue Ann Costa Clemens, Lily Weckx, Ralf Clemens, et al.
The Journal of Infectious Diseases|July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in CommunitiesDima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Nature Communications|January 14, 2025
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatmentSandra Viz-Lasheras, Alberto Gómez-Carballa, Xabier Bello, et al.
Archives of Disease in Childhood|August 28, 2023
External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised childrenAlexander James Martin, Fabian Johannes Stanislaus van der Velden, Ulrich von Both, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Pageof 100